Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2019 Feb 10;122(4):381–386. doi: 10.1016/j.anai.2019.02.002

Table 3:

Patterns of Medication Use, described in relation to whether child had a prior ICU admission

Valid % or mean (SD) or median [IQR] Overall No Prior ICU Admission Prior ICU Admission Unadjusted Odds of prior ICU admission compared to reference cat. a
N=160 (72.1%) N=62 (27.9%) OR (95% CI), p-value
Asthma Medication Fills Past 12 Months:£
No Controllers 27.9% 30.0% 22.6% Reference
Monotherapy Controller Therapy 36.5% 40.6% 25.8% 0.84 (0.38-1.89), p=0.681
Combination Controller Therapy 35.6% 29.4% 51.6% 2.33 (1.11-4.92), p=0.026
Asthma Medication Prescription Fills Over 12 months Prior to Study Enrollment-Specific type
No Controllers 27.9% 30.0% 22.6%
Monotherapy- Inhaled Corticosteroid (ICS) 35.6% 40.0% 24.2%
Monotherapy- Leukotriene Modifier (LTM) 0.9% 0.6% 1.6%
Combination- ICS+LTM 23.9% 20.6% 32.3%
Combination- ICS+Long Acting Beta Agonist (LABA) 1.8% 1.9% 1.6%
Combination- ICS +LABA+LTM 9.9% 6.9% 17.7%
Rescue Medication Fills
Short Acting Beta Agonist (SABA) fills, median (IQR) 2.0 (1.0-4.0) 2.0 (1.0-4.0) 3.0 (1.0-5.0) ----
 SABA,%≥4 SABA Rx fills 32.4% 28.1% 43.5% 1.97 (1.07-3.62), p=0.029
Oral Corticosteroid (OCS) fills, median (IQR) 1.0 (0.0-2.0) 1.0 (0.0-2.0) 1.0 (0.0-2.0) ----
 OCS % ≥2 OCS Rx fills 35.1% 33.8% 38.7% 1.24 (0.68-2.28), p=0.488
HEDIS AMR, Mean (SD) 0.45 (0.27) 0.44 (0.28) 0.48 (0.24) 1.05 (0.93-1.17), p=0.447
 <0.50 47.7% 48.2% 46.4% Reference
 0.51-0.69 38.1% 37.6% 39.3% 1.09 (0.56-2.13), p=0.811
 ≥0.70 14.2% 14.2% 14.3% 1.05 (0.41-2.67), p=0.925
a

Per one unit increase in HEDIS AMR where value multiplied by 10 prior to input in logistic model (e.g. 0.10 transformed to 1.0 and 0.20 transformed to 2.0: a one unit increase on this scale indicates increase in odds with every 0.10 increase in HEDIS AMR)

p<0.05,

£

p<0.01: Distributional difference between prior ICU groups assessed for significance using chi-square test for categorical factors, and for continuous variable t-test when distribution normal and Mann-Whitney U test when departures from normality apparent.